Five‐year conditional survival for patients with hepatocellular carcinoma in Queensland, Australia

Author:

Valery Patricia C.12ORCID,Baade Peter A.3,Stuart Katherine A.4,Leggett Barbara A.5,Macdonald Graeme A.4,Whiteman David C.1,Crawford Darrell H.2,Clark Paul J.1246

Affiliation:

1. Population Health QIMR Berghofer Medical Research Institute Brisbane Australia

2. School of Medicine University of Queensland Brisbane Australia

3. Cancer Council Queensland Brisbane Australia

4. Department of Gastroenterology and Hepatology Princess Alexandra Hospital Brisbane Australia

5. Department of Gastroenterology and Hepatology Royal Brisbane and Women's Hospital Brisbane Australia

6. Department of Gastroenterology and Hepatology Mater Hospitals Brisbane Australia

Funder

National Health and Medical Research Council

Publisher

Hindawi Limited

Reference34 articles.

1. Australian Institute of Health and Welfare.Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Canberra 2012.

2. National trends and disparities in the incidence of hepatocellular carcinoma, 1998–2003;Ahmed F;Prev Chronic Dis,2008

3. Liver cancer is the fastest increasing cause of cancer death in Australians

4. Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome

5. Projections of primary liver cancer to 2030 in 30 countries worldwide

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3